Neuronal intranuclear hyaline inclusion disease

Area of Science:

• Neuroscience
• Pathology
• Genetics

Background:

• Neuronal intranuclear hyaline inclusion disease (NIHID) is a rare neurodegenerative disorder.
• Pathologically, NIHID is defined by eosinophilic intranuclear inclusions in neurons and glial cells.
• Previous NIHID cases exhibited significant clinical variability, suggesting heterogeneity.

Purpose of the Study:

• To review and categorize reported NIHID cases into distinct clinical subgroups based on onset and duration.
• To discuss the clinical phenotype associated with each identified NIHID subgroup.
• To explore the potential pathogenetic mechanisms underlying NIHID, including the role of intranuclear inclusions.

Main Methods:

• Systematic review of reported Neuronal intranuclear hyaline inclusion disease cases.
• Categorization of cases into three clinical subgroups based on disease onset and duration.
• Analysis of pathological features, specifically ubiquitinated neuronal intranuclear inclusions (NII).

Main Results:

• NIHID cases were classified into three clinical subgroups with distinct phenotypes.
• Neuronal intranuclear inclusions (NII) in NIHID are ubiquitinated.
• The prevalence of NII is inversely correlated with neuronal loss, suggesting a protective role.

Conclusions:

• NIHID pathogenesis remains unclear but may involve unidentified abnormal proteins or impaired intranuclear ubiquitin-proteasome pathway function.
• The formation of NII in NIHID shares similarities with polyglutamine diseases, indicating a potential common proteolysis-related nuclear process.
• NII formation might represent a protective cellular response within the ubiquitin-proteasome-dependent proteolytic pathway.